{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:16:58Z","timestamp":1790979418355,"version":"4.1.0"},"reference-count":49,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"United Fund of Natural Sciences Foundation of Liaoning Province","award":["2023-MSLH-030"],"award-info":[{"award-number":["2023-MSLH-030"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Glioblastoma (GBM) is the most aggressive malignancy of the central nervous system (CNS) and is characterized by poor prognosis and significant resistance to available treatments. Surgery, radiation therapy, and chemotherapy are the standard treatments; however, their efficacy is often limited by resistance. Resveratrol (RES), a naturally occurring polyphenol with antioxidant properties, has shown significant anticancer effects through inhibition of multiple cellular pathways. However, our earlier research revealed that the LN428 cell exhibited resistance, while the U251 cell showed sensitivity to RES monotherapy. Hence, RES and AG490, a JAK2 inhibitor, were used to overcome GBM cell resistance, which might enhance therapeutic efficacy. Methods: Human GBM cell lines LN428 and U251 were used. CCK-8, H&amp;E staining, transwell, wound healing, calcein AM\/PI, and flow cytometry assays were performed to evaluate cell proliferation, migration, and apoptosis. Molecular docking was performed to analyze the binding energy. Western blot, immunocytochemistry (ICC), and immunofluorescence (IF) were used to assess protein expression following treatment with RES, AG490, and their combination. Results: The results revealed that U251 cells were more sensitive to RES, AG490, and RES + AG490 than LN428 cells. Additionally, the combination of both compounds significantly reduced cell viability, proliferation, and migration, while increasing apoptosis in the LN428 and U251 cell lines. Moreover, the combination of RES and AG490 led to increased BAX protein expression while decreasing BCL-2 expression in LN428 and U251 cell lines. Notably, the monotherapy administration of RES did not significantly inhibit STAT3 or pSTAT3 protein expression in LN428 cells, while combination therapy significantly inhibited the expression of these proteins in LN428 and U251 cell lines. Conclusions: The concurrent administration of RES and AG490 effectively inhibited the JAK2\/STAT3 signalling pathway and enhanced antitumor effects in GBM cells, indicating their potential as a therapeutic strategy.<\/jats:p>","DOI":"10.3390\/cancers18050794","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:18:45Z","timestamp":1772554725000},"page":"794","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Resveratrol and AG490 Overcome Glioblastoma Cells\u2019 Resistance to Monotherapy by Inhibiting JAK2\/STAT3 Signalling Pathway"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6929-4078","authenticated-orcid":false,"given":"Aziz","family":"Ullah","sequence":"first","affiliation":[{"name":"Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanchun","family":"Han","sequence":"additional","affiliation":[{"name":"Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"152058","DOI":"10.1016\/j.acthis.2023.152058","article-title":"Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths","volume":"125","author":"Aliashrafzadeh","year":"2023","journal-title":"Acta Histochem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1471-4159.2012.07781.x","article-title":"Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells","volume":"122","author":"Happold","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.3892\/or.2017.5964","article-title":"PomGnT1 enhances temozolomide resistance by activating epithelial-mesenchymal transition signaling in glioblastoma","volume":"38","author":"Liu","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2147\/JIR.S353489","article-title":"Role of JAK2\/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic Review","volume":"15","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Jensen, K.V., Cseh, O., Aman, A., Weiss, S., and Luchman, H.A. (2017). The JAK2\/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft model. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0189670"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12967-015-0627-5","article-title":"Effect of the JAK2\/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres","volume":"13","author":"Mukthavaram","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2017.01.004","article-title":"The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment","volume":"451","author":"Chang","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11060-010-0273-y","article-title":"Inhibition of the JAK-2\/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells","volume":"101","author":"Senft","year":"2011","journal-title":"J. Neuro-Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s12935-021-02099-0","article-title":"Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: A mechanistic review","volume":"21","author":"Arabzadeh","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ibrahim, R.S., Ibrahim, S.S., El-Naas, A., Koklesov\u00e1, L., Kubatka, P., and B\u00fcsselberg, D. (2023). Could Metformin and Resveratrol Support Glioblastoma Treatment? A Mechanistic View at the Cellular Level. Cancers, 15.","DOI":"10.3390\/cancers15133368"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s13311-014-0334-6","article-title":"Diffusion Efficiency and Bioavailability of Resveratrol Administered to Rat Brain by Different Routes: Therapeutic Implications","volume":"12","author":"Shu","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_12","first-page":"25","article-title":"Resveratrol downregulates PI3K\/Akt\/mTOR signaling pathways in human U251 glioma cells","volume":"8","author":"Jiang","year":"2009","journal-title":"J. Exp. Ther. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.3390\/nu7064383","article-title":"Resveratrol Inhibits the Invasion of Glioblastoma-Initiating Cells via Down-Regulation of the PI3K\/Akt\/NF-\u03baB Signaling Pathway","volume":"7","author":"Jiao","year":"2015","journal-title":"Nutrients"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"v81","DOI":"10.1093\/neuonc\/nou255.11","article-title":"ET-11: Resveratrol regulates glioblastoma and glioblastoma stem-like cells via anti-tumorigenic akt dephosphorylation and p53 activation","volume":"16","author":"Clark","year":"2014","journal-title":"Neuro-Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"75790","DOI":"10.18632\/oncotarget.12414","article-title":"Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas","volume":"7","author":"Song","year":"2016","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wu, M., Song, D., Li, H., Ahmad, N., Xu, H., Yang, X., Wang, Q., Cheng, X., Deng, S., and Shu, X. (2023). Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119453"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.2147\/CMAR.S258584","article-title":"Synergistic Effects of Resveratrol and Temozolomide Against Glioblastoma Cells: Underlying Mechanism and Therapeutic Implications","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_18","first-page":"51","article-title":"JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2\/STAT3 signaling","volume":"31","author":"Fu","year":"2017","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Stylli, S.S. (2020). Novel Treatment Strategies for Glioblastoma. Cancers, 12.","DOI":"10.3390\/cancers12102883"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_22","first-page":"6373","article-title":"Curcumin for the Treatment of Glioblastoma","volume":"35","author":"Sordillo","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12640-013-9452-x","article-title":"Quercetin and sorafenib as a novel and effective couple in programmed cell death induction in human gliomas","volume":"26","author":"Langner","year":"2014","journal-title":"Neurotox. Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Cirone, M., Di Renzo, L., Lotti, L.V., Conte, V., Trivedi, P., Santarelli, R., Gonnella, R., Frati, L., and Faggioni, A. (2012). Primary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031732"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12672-025-02567-3","article-title":"Glioblastoma multiforme: An updated overview of temozolomide resistance mechanisms and strategies to overcome resistance","volume":"16","author":"Pu","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3892\/ijo.2014.2250","article-title":"Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the Jak2\/STAT3 pathway","volume":"44","author":"Joung","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_28","first-page":"e1353","article-title":"Resveratrol-loaded nanomedicines for cancer applications","volume":"4","author":"Annaji","year":"2021","journal-title":"Cancer Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.18632\/genesandcancer.15","article-title":"Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells","volume":"5","author":"Zhang","year":"2014","journal-title":"Genes Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Nie, J.H., Li, H., Wu, M.L., Lin, X.M., Xiong, L., and Liu, J. (2019). Differential Exosomic Proteomic Patterns and Their Influence in Resveratrol Sensitivities of Glioblastoma Cells. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20010191"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7150\/jca.45489","article-title":"Increased Reactive Oxygen Species and Distinct Oxidative Damage in Resveratrol-suppressed Glioblastoma Cells","volume":"12","author":"Jia","year":"2021","journal-title":"J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F","article-title":"General mechanisms of metastasis","volume":"80","author":"Woodhouse","year":"1997","journal-title":"Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e00431","DOI":"10.1016\/j.neurot.2024.e00431","article-title":"Pyrimidine compounds BY4003 and BY4008 inhibit glioblastoma cells growth via modulating JAK3\/STAT3 signaling pathway","volume":"21","author":"Ahmad","year":"2024","journal-title":"Neurotherapeutics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3892\/ol.2015.3888","article-title":"Resveratrol suppresses human glioblastoma cell migration and invasion via activation of RhoA\/ROCK signaling pathway","volume":"11","author":"Xiong","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3171\/2016.1.JNS152077","article-title":"Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration","volume":"126","author":"Clark","year":"2017","journal-title":"J. Neurosurg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41419-022-05207-8","article-title":"Nintedanib induces senolytic effect via STAT3 inhibition","volume":"13","author":"Cho","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.canlet.2010.07.015","article-title":"Targeting apoptosis pathways in cancer by Chinese medicine","volume":"332","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Rabah, N., Ait Mohand, F.E., and Kravchenko-Balasha, N. (2023). Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241814256"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"21486","DOI":"10.1038\/s41598-024-72475-z","article-title":"Uncovering naringin\u2019s anticancer mechanisms in glioblastoma via molecular docking and network pharmacology approaches","volume":"14","author":"Ashtekar","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez-Jim\u00e9nez, L.K., Rivera, G., Ju\u00e1rez-Saldivar, A., Ortega-Balleza, J.L., Ortiz-P\u00e9rez, E., Jaime-S\u00e1nchez, E., Paz-Gonz\u00e1lez, A., and Lara-Ram\u00edrez, E.E. (2024). Biological Evaluations and Computer-Aided Approaches of Janus Kinases 2 and 3 Inhibitors for Cancer Treatment: A Review. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16091165"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5540139","DOI":"10.1155\/2021\/5540139","article-title":"Fraxetin Inhibits the Proliferation and Metastasis of Glioma Cells by Inactivating JAK2\/STAT3 Signaling","volume":"2021","author":"Qu","year":"2021","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8228","DOI":"10.1158\/1078-0432.CCR-08-1329","article-title":"The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas","volume":"14","author":"Yang","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Tolomeo, M., and Cascio, A. (2021). The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020603"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2017.12.003","article-title":"The role of STAT3 in leading the crosstalk between human cancers and the immune system","volume":"415","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3892\/ol.2017.6353","article-title":"Characterization of the aminopyridine derivative KRC-180 as a JAK2 inhibitor","volume":"14","author":"Yoon","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"149761","DOI":"10.1016\/j.gene.2025.149761","article-title":"Role of Notch and its oncogenic signaling crosstalk in glioma and glioma stem cells","volume":"969","author":"Sidhu","year":"2025","journal-title":"Gene"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-3-030-30651-9_10","article-title":"STAT Signaling in Glioma Cells","volume":"1202","author":"Kaminska","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00432-024-05625-5","article-title":"Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2\/STAT3 pathway","volume":"150","author":"Zhang","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ou, A., Ott, M., Fang, D., and Heimberger, A.B. (2021). The Role and Therapeutic Targeting of JAK\/STAT Signaling in Glioblastoma. Cancers, 13.","DOI":"10.3390\/cancers13030437"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/5\/794\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:29:55Z","timestamp":1772641795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/5\/794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cancers18050794"],"URL":"https:\/\/doi.org\/10.3390\/cancers18050794","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]}}}